Catalent
CTLT
#1594
Rank
HK$84.52 B
Marketcap
HK$465.68
Share price
-0.05%
Change (1 day)
71.03%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of June 2024 : HK$38.22 Billion

According to Catalent's latest financial reports the company's total debt is HK$38.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30HK$38.09 B15.17%
2022-06-30HK$33.07 B30.82%
2021-06-30HK$25.28 B7.57%
2020-06-30HK$23.50 B1.66%
2019-06-30HK$23.12 B8.26%
2018-06-30HK$21.35 B31.59%
2017-06-30HK$16.23 B12.44%
2016-06-30HK$14.43 B-0.99%
2015-06-30HK$14.57 B-30.61%
2014-06-30HK$21.01 B0.64%
2013-06-30HK$20.87 B0.29%
2012-06-30HK$20.81 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$0.31 B-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.61 B-93.15%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$45.01 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$1.73 B-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA